newsfilter
← Latest News
PR Newswire·

Stealth BioTherapeutics Corp Announces Completion of Merger

BOSTON, Nov. 16, 2022 /PRNewswire/ -- Stealth BioTherapeutics Corp (NASDAQ:MITO) (the "Company" or "Stealth BioTherapeutics"), a clinical-stage biotechnology company focused on the discovery, development,